187 related articles for article (PubMed ID: 8847023)
1. DNA ploidy as a prognostic factor for patients with an adenocarcinoma in Barrett's esophagus.
Menke-Pluymers MB; Hop WC; Mulder AH; Tilanus HW
Hepatogastroenterology; 1995; 42(6):786-8. PubMed ID: 8847023
[TBL] [Abstract][Full Text] [Related]
2. [Dna ploidy in adenocarcinoma of Barrett's esophagus].
Flejou JF; Doublet B; Potet F; Metayer J; Hemet J
Ann Pathol; 1990; 10(3):161-5. PubMed ID: 2386598
[TBL] [Abstract][Full Text] [Related]
3. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of DNA ploidy patterns of colorectal adenocarcinoma.
Lin JK; Chang SC; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2003; 50(54):1927-32. PubMed ID: 14696434
[TBL] [Abstract][Full Text] [Related]
5. Role of DNA content determination by image analysis in confirmation of dysplasia in Barrett's esophagus.
Khan M; Bui HX; del Rosario A; Abdulla M; Ballouk F; Sim YJ; Ross JS
Mod Pathol; 1994 Feb; 7(2):169-74. PubMed ID: 8008738
[TBL] [Abstract][Full Text] [Related]
6. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of tumor ploidy and histomorphological parameters in adenocarcinoma of Barrett's esophagus.
Böttger T; Dutkowski P; Kirkpatrick CJ; Junginger T
Dig Surg; 1999; 16(3):180-5. PubMed ID: 10436364
[TBL] [Abstract][Full Text] [Related]
9. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R
Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806
[TBL] [Abstract][Full Text] [Related]
10. [Demonstration of clonal heterogeneity in adenocarcinomas on Barrett's esophagus by flow cytometric study of cellular DNA content].
Robaszkiewicz M; Volant A; Hardy E; Nousbaum JB; Calament G; Cauvin JM; Bail JP; Lozach P; Gouerou H
Gastroenterol Clin Biol; 1992; 16(6-7):540-6. PubMed ID: 1526415
[TBL] [Abstract][Full Text] [Related]
11. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
Santoro E; Carboni M; Catarci M; Carlini M; Carboni F; Zupi G; Vecchione A; D'Agnano I; Giannarelli D; Santoro R; Garofalo A
Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
[TBL] [Abstract][Full Text] [Related]
12. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
13. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
[TBL] [Abstract][Full Text] [Related]
14. Beta 1 integrin expression in adenocarcinoma of Barrett's esophagus.
Bottger TC; Youssef V; Dutkowski P; Seifert J; Maschek H; Brenner W; Junginger T
Hepatogastroenterology; 1999; 46(26):938-43. PubMed ID: 10370643
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of histomorphological parameters and DNA content and their therapeutic consequences in esophageal carcinoma: a multivariate approach.
Boettger T; Dutkowski P; Kirkpatrick CJ; Seifert JK; Junginger T
Hepatogastroenterology; 1998; 45(22):994-1004. PubMed ID: 9755996
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of TGF-beta1 in esophageal (Barrett's) adenocarcinoma is associated with advanced stage of disease and poor prognosis.
von Rahden BH; Stein HJ; Feith M; Pühringer F; Theisen J; Siewert JR; Sarbia M
Mol Carcinog; 2006 Oct; 45(10):786-94. PubMed ID: 16921482
[TBL] [Abstract][Full Text] [Related]
17. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma arising in Barrett's esophagus.
Li H; Walsh TN; Hennessy TP
Surg Gynecol Obstet; 1992 Aug; 175(2):167-72. PubMed ID: 1636141
[TBL] [Abstract][Full Text] [Related]
19. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
